Skip to main content
SpringerLink
Log in

Adjuvant Chemotherapy and Follow-Up

  • Chapter
  • First Online:
Surgical Treatment of Colorectal Liver Metastases

Part of the book series: Updates in Surgery ((UPDATESSURG))

  • 712 Accesses

Abstract

Even though there are no definitive data supporting the use of adjuvant chemotherapy after liver resection for initially resectable hepatic colorectal metastases, the rationale for this approach seems evident. The activity of chemotherapy in metastatic disease is well known, and it is broadly accepted that, at least theoretically, patients with micrometastatic disease after radical surgery will benefit from systemic chemotherapy, as will patients undergoing surgery for stage III colon cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345:939–944

    Article  Google Scholar 

  2. Goldberg RM, Hatfield AK, Kahn M et al (1997) Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer. J Clin Oncol 15:3320–3329

    Article  CAS  Google Scholar 

  3. Moertel CG, Fleming TR, Macdonald JS et al (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 122:321–326

    Article  CAS  Google Scholar 

  4. Wolmark N, Rockette H, Fisher B et al (1993) The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 11:1879–1887

    Article  CAS  Google Scholar 

  5. Mamounas E, Wieand S, Wolmark N et al (1999) Comparative efficacy of adjuvant chemotherapy in patients with Dukes’ B versus Dukes’ C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 17:1349–55

    Article  CAS  Google Scholar 

  6. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. (1999) J Clin Oncol 17:1356–63

    Google Scholar 

  7. Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351

    Article  CAS  Google Scholar 

  8. Wolmark N, Kuebler JP, Colangelo L et al (2005) A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Results of NSABP Protocol C-07. Proc Amer Soc Clin Oncol (abstr # 3500)

    Google Scholar 

  9. Sargent DJ, Wieand HS, Haller DG et al (2005) Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 23:8664–8670

    Article  Google Scholar 

  10. Twelves C, Wong A, Nowacki MP et al (2005) Capecitabine as adjuvant treatment for stage III colon cancer (X-ACT Trial). N Engl J Med 352:2696–2704

    Article  CAS  Google Scholar 

  11. Scheithauer W, McKendrick J, Begbie et al (2003) Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: Safety results of a randomized, phase III trial. Ann Oncol 14:1735–1743

    Article  CAS  Google Scholar 

  12. Haller D, Tabernero J, Maroun J et al (2009) First efficacy findings from a randomized phase III trial of capecitabine + oxaliplatin vs. bolus 5-FU/LV for stage III colon cancer (NO16968/XELOXA study). Joint ECCO 15–34th ESMO Multidisciplinary Congress. Abstract #5LBA

    Google Scholar 

  13. Parks R, Gonen M, Kemeny N et al (2007) Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg 204:753–761

    Article  Google Scholar 

  14. Fong Y, Fortner JG, Sun R et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–321

    Article  CAS  Google Scholar 

  15. Lygidakis NJ, Ziras N, Parissis J (1995) Resection versus resection combined with adjuvant pre-and post-operative chemotherapy-immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 42:155–161

    CAS  PubMed  Google Scholar 

  16. Asahara T, Kikkawa M, Okajima M et al (1998) Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy. Hepatogastroenterology 45:805–811

    CAS  PubMed  Google Scholar 

  17. Lorenz M, Müller HH, Schramm H et al (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer: German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 228:756–762

    Article  CAS  Google Scholar 

  18. Kemeny MM, Adak S, Gray B et al (2002) Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an Intergroup study. J Clin Oncol 20:1499–1505

    PubMed  Google Scholar 

  19. Tono T, Hasuike Y, Ohzato H et al (2000) Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study. Cancer 88:1549–1556

    Article  CAS  Google Scholar 

  20. Lygidakis NJ, Sgourakis G, Vlachos L et al (2001) Metastatic liver disease of colorectal origin: The value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection: Results of a prospective randomized study. Hepatogastroenterology 48:1685–1691

    CAS  PubMed  Google Scholar 

  21. Kemeny N, Huang Y, Cohen AM et al (1999) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039–2048

    Article  CAS  Google Scholar 

  22. Kemeny NE, Gonen M (2005) Hepatic arterial infusion after liver resection. N Engl J Med 352:734–735

    Article  CAS  Google Scholar 

  23. Portier G, Elias D, Bouche O et al (2006) Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24:4976–4982

    Article  CAS  Google Scholar 

  24. Langer B, Bleiberg H, Labianca R et al (2002) Fluorouracil (FU) plus l-leucovorin (l-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): Results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. J Clin Oncol 21(abstr 592)

    Google Scholar 

  25. Mitry E, Fields A, Bleiberg H et al (2008) Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer. A meta-analysis of two randomized trials. J Clin Oncol 26:4906–4911

    Article  CAS  Google Scholar 

  26. Ychoul M, Hohenberger W, Thezenas S et al (2009) A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol 20:1964–1970

    Article  Google Scholar 

  27. Power DG, Kemeny NE (2010) Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol 28:2300–2309

    Article  CAS  Google Scholar 

  28. Muratore A, Polastri R, Bouzari H et al (2001) Repeat hepatectomy for colorectal liver metastases: a worthwhile operation? J Surg Oncol 76:127–132

    Article  CAS  Google Scholar 

  29. Petrowsky H, Gonen M, Jarnagin W et al (2002) Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235:863–871

    Article  Google Scholar 

  30. Adam R, Pascal G, Azoulay D et al (2003) Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238:871–884

    Article  Google Scholar 

  31. Saito Y, Omiya H, Kohno K et al (2002) Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 124:1007–1013

    Article  Google Scholar 

  32. Secco GB, Fardelli R, Gianquinto D et al (2002) Efficacy and cost of risk adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 28:418–423

    Article  Google Scholar 

  33. Rodriguez-Moranta F, Salo J, Arcusa A et al (2005) Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: A prospective, multicenter, randomized, controlled trial. J Clin Oncol 24:1–8

    Google Scholar 

  34. Figueredo A, Rumble RB, Maroun J et al (2003) Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 3:26

    Article  Google Scholar 

  35. Tjandra JJ, Chan MK (2007) Follow-up after curative resection of colorectal cancer: a metaanalysis. Dis Col Rect 50:1783–1799

    Article  Google Scholar 

  36. Desch CE, Benson III AB, Somerfield MR et al (2005) Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline. J Clin Oncol 23:8512–8519

    Article  Google Scholar 

  37. Tsikitis VL, Malireddy K, Green EA et al (2009) Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J Clin Oncol 27:3671–3676

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Medical Oncology, Institute for Cancer Research and Treatment, Candiolo (TO), Italy

    Francesco Leone

Authors
  1. Francesco Leone
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Hepato-Bilio-Pancreatic and Digestive Surgery, Mauriziano “Umberto I” Hospital, Turin, Italy

    Lorenzo Capussotti (Chief of the Surgical Department, Director) (Chief of the Surgical Department, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Italia

About this chapter

Cite this chapter

Leone, F. (2011). Adjuvant Chemotherapy and Follow-Up. In: Capussotti, L. (eds) Surgical Treatment of Colorectal Liver Metastases. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-1809-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1809-9_10

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1808-2

  • Online ISBN: 978-88-470-1809-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation